至正股份(603991.SH):遊桂玲擬受讓5.02%的股份
格隆匯 12 月 14日丨至正股份(603991.SH)公佈,公司於2020年12月14日收到公司股東上海至正企業集團有限公司(“至正集團”)和安徽安益大通股權投資合夥企業(有限合夥)(“安益大通”)的通知,至正集團和安益大通與自然人遊桂玲於2020年12月14日簽訂了《股份轉讓協議》,至正集團和安益大通分別將其持有的364.2081萬股和10萬股公司股份轉讓予自然人遊桂玲。
此次權益變動前,遊桂玲未持有公司股份。此次權益變動後,遊桂玲持有公司374.2081萬股股份,佔公司總股本的5.02%,成為公司持股5%以上的股東。此次權益變動不會導致公司控股股東及實際控制人發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.